Winton Group LTD Madrigal Pharmaceuticals, Inc. Transaction History

Winton Group LTD

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 30, 2020	SELL	$99.78 - $124.21 $1.15 Million - $1.43 Million	-11,535 Closed	0 $0
Q2 2020 Aug 05, 2020	BUY	$60.13 - $125.71 $370,641 - $774,876	6,164 Added 114.76%	11,535 $1.31 Million
Q1 2020 May 11, 2020	SELL	$66.76 - $93.49 $54,075 - $75,726	-810 Reduced 13.1%	5,371 $359,000
Q4 2019 Feb 13, 2020	BUY	$84.28 - $118.5 $520,934 - $732,448	6,181 New	6,181 $563,000
Q1 2019 May 13, 2019	SELL	$103.48 - $143.84 $536,750 - $746,098	-5,187 Closed	0 $0
Q4 2018 Feb 05, 2019	BUY	$94.77 - $215.54 $186,791 - $424,829	1,971 Added 61.29%	5,187 $585,000
Q3 2018 Nov 02, 2018	BUY	$207.3 - $300.31 $361,116 - $523,140	1,742 Added 118.18%	3,216 $0
Q2 2018 Aug 20, 2018	SELL	$101.55 - $313.9 $111,400 - $344,348	-1,097 Reduced 42.67%	1,474 $0
Q1 2018 May 21, 2018	BUY	$93.35 - $149.04 $240,002 - $383,181	2,571 New	2,571 $0

296

22M

819K

640K

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $5.8B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

Stay updated on Winton Group LTD with notifications on news.